Summary: HuffPost Live discusses the therapeutic potential of psilocybin, highlighting clinical research into psilocybin-assisted psychotherapy to treat depression, anxiety, and addiction. Mycophilia author Eugenia Bone speaks about the science of psilocybin mushrooms, Reason editor Jacob Sullum contextualizes the political dynamics of psychedelic research, and Acid Test author Tom Shroder chronicles the progression of psychedelic-assisted psychotherapy research from the 1950’s to today.
Originally appearing here.
Recent studies have found that psilocybin, the naturally occurring chemical in psychoactive mushrooms, may help those suffering from depression and anxiety. Is it time to rethink our approach to psychedelic substances?
